In this article, we will look at the 10 Best Slow Growth Stocks to Buy According to Analysts.
Slow growth stocks are not usually the part of the market that grabs attention first. They do not come with the same excitement as aggressive revenue stories. But when the market gets more selective, investors often start paying closer attention to companies that may not be growing explosively but have shown they can keep moving forward with fewer surprises. MFS makes that case clearly, arguing that companies with “resilient earnings” and “strong balance sheets” tend to “create value more consistently over time.”
The broader institutional commentary points in the same direction. Invesco says quality companies tend to “generate stable earnings” and can offer “downside resilience alongside steadier performance,” which helps explain why slower but more dependable growers often hold up better when the market becomes less forgiving. T. Rowe Price says, “not all growth is created equal.” The firm argues that the more attractive growth profile may actually be the one built on “consistent growth on the top and bottom lines” and “less variability in their earnings.”
That is why slow growth stocks can still deserve a place on the buy list, especially when analysts remain constructive on companies with durable earnings, disciplined balance sheets, and a record of showing up quarter after quarter. That brings us to the 10 Best Slow Growth Stocks to Buy According to Analysts.
Our Methodology
We used the Finviz screener to identify stocks that exhibited EPS growth lower than 10% annually in the last 5 years and forecasted to grow below 10% in the next 5 years. Thereafter, we filtered for names that are viewed favorably by analysts. We then limited our final selection to companies that have recently reported noteworthy developments likely to impact investor sentiment. These stocks are also popular among analysts and elite hedge funds.
Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 498.7% since May 2014, beating its benchmark by 303 percentage points (see more details here).
10. Evergy, Inc. (NASDAQ:EVRG)
On April 21, 2026, Wells Fargo analyst Shahriar Pourreza raised the price target on Evergy, Inc. (NASDAQ:EVRG) to $87 from $83 and maintained an Equal Weight rating. Following discussions with companies, the firm updated its Q1 2026 estimates to reflect known and measurable drivers across its regulated utility coverage and increased its base value multiple to 17.5 times from 17 times.
On April 9, 2026, BTIG initiated coverage of Evergy, Inc. (NASDAQ:EVRG) with a Buy rating and a $99 price target, saying the company has “taken steps toward an elevated growth story” after a period of “muted” growth. The firm views the 6%–8% earnings growth outlook as “reasonable and potentially conservative,” citing the potential for additional large loads and an improving regulatory environment.
Meanwhile, BofA lowered its price target on Evergy, Inc. (NASDAQ:EVRG) to $88 from $89 and maintained a Buy rating, keeping its 2026–2030 EPS estimates unchanged while adjusting the price target based on updated peer group multiples.
Evergy, Inc. (NASDAQ:EVRG) generates, transmits, distributes, and sells electricity in the United States.
9. Danaher Corporation (NYSE:DHR)
On April 21, 2026, Danaher Corporation (NYSE:DHR) reported Q1 adjusted EPS of $2.06, above the $1.94 consensus, with revenue of $6B in line with expectations. Rainer Blair said the company “executed well in the first quarter,” citing nearly 10% adjusted EPS growth, continued recovery in Bioprocessing, and better-than-expected performance in Life Sciences, which helped offset a lighter respiratory season at Cepheid. Rainer Blair also pointed to the planned acquisition of Masimo Corporation, noting opportunities to improve performance through scale and operating capabilities.
The company raised its FY26 adjusted EPS outlook to $8.35–$8.55 from $8.35–$8.50, compared with a $8.40 consensus, and reiterated expectations for non-GAAP core revenue growth of 3% to 6% year-over-year. Danaher also highlighted its balance sheet and free cash flow generation as supporting further capital deployment.
Following the results, Jefferies analyst Tycho Peterson raised the price target on Danaher Corporation (NYSE:DHR) to $245 from $240 and maintained a Buy rating after what was described as a “solid” Q1, noting easing headwinds, emerging growth signals, and valuation that is “not demanding.”
Danaher Corporation (NYSE:DHR) designs, manufactures, and markets professional, medical, research, and industrial products and services globally.
